2024 Q2 Form 10-Q Financial Statement

#000143774924015124 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $21.81M $25.43M $116.5M
YoY Change 271.05% 205.54% 925.53%
Cost Of Revenue $12.31M $3.225M $14.80M
YoY Change 1163.49% 180.42% 1579.63%
Gross Profit $9.499M $22.20M $101.7M
YoY Change 93.71% 209.56% 870.5%
Gross Profit Margin 43.55% 87.32% 87.29%
Selling, General & Admin $5.530M $7.876M $7.382M
YoY Change 24.95% 85.96% 25.64%
% of Gross Profit 58.22% 35.47% 7.26%
Research & Development $2.889M $3.053M $2.618M
YoY Change -43.53% -39.49% -59.14%
% of Gross Profit 30.41% 13.75% 2.57%
Depreciation & Amortization $140.8K $100.0K $137.6K
YoY Change 5.37% 0.0% 4.87%
% of Gross Profit 1.48% 0.45% 0.14%
Operating Expenses $8.419M $10.93M $10.00M
YoY Change -11.77% 17.76% -18.58%
Operating Profit $1.080M $11.28M $91.68M
YoY Change -123.28% -634.81% -5179.91%
Interest Expense $0.00
YoY Change
% of Operating Profit 0.0%
Other Income/Expense, Net $1.318M $1.942M $1.191M
YoY Change 10.69% 118.1% 75.87%
Pretax Income $2.398M $13.22M $92.87M
YoY Change -169.55% -1185.5% -8336.93%
Income Tax $600.0K $2.900M $20.61M
% Of Pretax Income 25.02% 21.94% 22.2%
Net Earnings $1.833M $10.28M $72.26M
YoY Change -163.73% -1219.23% -9000.78%
Net Earnings / Revenue 8.4% 40.41% 62.03%
Basic Earnings Per Share $0.03 $0.14
Diluted Earnings Per Share $0.03 $0.14 $1.00
COMMON SHARES
Basic Shares Outstanding 71.12M 71.09M 71.09M
Diluted Shares Outstanding 71.75M 71.56M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.9M $143.9M $150.1M
YoY Change 40.33% 24.37% 51.98%
Cash & Equivalents $106.9M $143.9M $150.1M
Short-Term Investments
Other Short-Term Assets $4.907M $2.175M $3.496M
YoY Change 214.4% 11.05% 50.97%
Inventory $55.66M $63.72M $64.22M
Prepaid Expenses
Receivables $8.954M $18.13M $21.13M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $176.5M $227.9M $239.0M
YoY Change 31.41% 32.09% 28.64%
LONG-TERM ASSETS
Property, Plant & Equipment $1.517M $1.193M $1.332M
YoY Change -5.48% -30.51% -27.95%
Goodwill $898.3K $898.3K $898.3K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.156M $2.149M $13.13M
YoY Change 1.82% 5.3% 5099.71%
Total Long-Term Assets $16.18M $15.25M $15.36M
YoY Change 32.51% 33.91% 66.08%
TOTAL ASSETS
Total Short-Term Assets $176.5M $227.9M $239.0M
Total Long-Term Assets $16.18M $15.25M $15.36M
Total Assets $192.7M $243.1M $254.4M
YoY Change 31.5% 32.2% 30.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.033M $2.523M $1.456M
YoY Change -4.46% 121.38% -56.6%
Accrued Expenses $6.533M $6.123M $7.522M
YoY Change -63.49% -61.73% -55.37%
Deferred Revenue $13.73M $20.79M $20.79M
YoY Change 20.7% 97.58% 96.47%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.38M $74.81M $54.12M
YoY Change 12.59% 304.9% 151.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.722M $3.343M $3.376M
YoY Change 7.93% -0.34% 0.54%
Total Long-Term Liabilities $3.722M $3.343M $3.376M
YoY Change 7.93% -0.34% 0.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.38M $74.81M $54.12M
Total Long-Term Liabilities $3.722M $3.343M $3.376M
Total Liabilities $25.10M $78.16M $57.49M
YoY Change 11.87% 258.0% 131.12%
SHAREHOLDERS EQUITY
Retained Earnings -$69.95M -$71.78M -$38.94M
YoY Change -36.87% -0.69% -38.96%
Common Stock $237.5M $236.8M $235.8M
YoY Change 1.12% 1.02% 0.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $167.6M $165.0M $196.9M
YoY Change
Total Liabilities & Shareholders Equity $192.7M $243.1M $254.4M
YoY Change 31.5% 32.2% 30.41%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $1.833M $10.28M $72.26M
YoY Change -163.73% -1219.23% -9000.78%
Depreciation, Depletion And Amortization $140.8K $100.0K $137.6K
YoY Change 5.37% 0.0% 4.87%
Cash From Operating Activities $5.953M -$6.118M $79.03M
YoY Change -266.29% -125.03% -1074.95%
INVESTING ACTIVITIES
Capital Expenditures $2.190K $0.00 $1.690K
YoY Change -89.9%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.190K $0.00 -$1.690K
YoY Change -89.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -42.87M -$159.0K -2.420K
YoY Change 19.53% -97.9% -99.92%
NET CHANGE
Cash From Operating Activities 5.953M -$6.118M 79.03M
Cash From Investing Activities -2.190K $0.00 -1.690K
Cash From Financing Activities -42.87M -$159.0K -2.420K
Net Change In Cash -36.92M -$6.277M 79.03M
YoY Change -6.46% -137.17% -821.16%
FREE CASH FLOW
Cash From Operating Activities $5.953M -$6.118M $79.03M
Capital Expenditures $2.190K $0.00 $1.690K
Free Cash Flow $5.951M -$6.118M $79.03M
YoY Change -265.23% -125.03% -1074.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71122516
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71122516
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71091616
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71091616
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 usd
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2024Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilities
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-23047
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3864870
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
31 East 62nd Street
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10065
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024Q1 dei City Area Code
CityAreaCode
212
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
672-9100
CY2024Q1 dei Security12b Title
Security12bTitle
common stock, $.0001 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
SIGA
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71122516
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143868648 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150145844 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18127180 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21130951 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
63721788 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
64218337 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2174993 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3496028 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
227892609 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
238991160 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1193237 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1331708 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11011668 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11048118 usd
CY2024Q1 us-gaap Goodwill
Goodwill
898334 usd
CY2023Q4 us-gaap Goodwill
Goodwill
898334 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2149482 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2083535 usd
CY2024Q1 us-gaap Assets
Assets
243145330 usd
CY2023Q4 us-gaap Assets
Assets
254352855 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2523350 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1456316 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6122929 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10181810 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
42673509 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20788720 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20788720 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2703690 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
21690899 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
74812198 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
54117745 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
3342927 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
3376203 usd
CY2024Q1 us-gaap Liabilities
Liabilities
78155125 usd
CY2023Q4 us-gaap Liabilities
Liabilities
57493948 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
7112 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7109 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
236766447 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
235795420 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71783354 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38943622 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
164990205 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
196858907 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
243145330 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
254352855 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25429855 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8323025 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3225314 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1150187 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7875773 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4235108 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3053369 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5046036 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
14154456 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
10431331 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11275399 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2108306 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1942437 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
890629 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13217836 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1217677 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2940496 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-299422 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
10277340 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-918255 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71093653
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72197038
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71562996
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72197038
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
10277340 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-918255 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
138471 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
131121 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1130010 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
408730 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36450 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-483425 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3003771 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33090256 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1512118 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3304697 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-239518 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1431530 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3468684 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3070721 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-18987210 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
25639 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6118216 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24447118 usd
CY2024Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
-0 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
-0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
158980 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7557057 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-158980 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7557057 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6277196 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16890061 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150145844 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98790622 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143868648 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115680683 usd
CY2024Q1 us-gaap Stock Issued1
StockIssued1
417000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
68700000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2024Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
16800000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1596579 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8061800 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
57886954 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
53649859 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4238255 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2506678 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
63721788 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
64218337 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6914657 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6914657 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5721420 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5582949 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1193237 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1331708 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2095059 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2477619 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1368907 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2974863 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1068513 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
445653 usd
CY2024Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
641606 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3300985 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
503470 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
564009 usd
CY2024Q1 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
445374 usd
CY2023Q4 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
418681 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6122929 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10181810 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
10277340 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-918255 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71093653
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72197038
CY2024Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
469343
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71562996
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72197038
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
13600000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25429855 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8323025 usd
CY2024Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
13200000 usd
CY2023Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1200000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2900000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222 pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.246 pure
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
196858907 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
10277340 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-158980 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
43117072 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1130010 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
164990205 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
170160042 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-918255 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7557057 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
408730 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
162093460 usd
CY2021Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1100000
CY2023Q1 siga Stock Repurchased During Period Value Gross
StockRepurchasedDuringPeriodValueGross
7500000 usd
CY2023Q1 siga Excise Tax On Corporate Shares Repurchased
ExciseTaxOnCorporateSharesRepurchased
100000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
100000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
200000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0453 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
454053 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
406994 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
409971 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
165916 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1436934 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
96381 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1340553 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
800000 usd

Files In Submission

Name View Source Status
0001437749-24-015124-index-headers.html Edgar Link pending
0001437749-24-015124-index.html Edgar Link pending
0001437749-24-015124.txt Edgar Link pending
0001437749-24-015124-xbrl.zip Edgar Link pending
ex_618556.htm Edgar Link pending
ex_618557.htm Edgar Link pending
ex_618558.htm Edgar Link pending
ex_618559.htm Edgar Link pending
ex_654007.htm Edgar Link pending
ex_654661.htm Edgar Link pending
ex_654662.htm Edgar Link pending
ex_654663.htm Edgar Link pending
ex_660603.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20240331.xsd Edgar Link pending
siga20240331_10q.htm Edgar Link pending
siga-20240331_cal.xml Edgar Link unprocessable
siga-20240331_def.xml Edgar Link unprocessable
siga-20240331_lab.xml Edgar Link unprocessable
siga-20240331_pre.xml Edgar Link unprocessable
siga20240331_10q_htm.xml Edgar Link completed